Completed NA INTERVENTIONAL 4-arm NCT01959607

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of THS 2.2 Following Single Use in Healthy Smokers Compared to Conventional Cigarettes and Nicotine Gum

Sponsor: Philip Morris Products S.A.

Conditions Smoking

Interventions CC NRT Gum THS 2.2

Updated 6 times since 2017 Last updated: Jan 15, 2025 Started: Jul 31, 2013 Primary completion: Nov 30, 2013 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Smoking, this trial is completed. The trial is conducted by Philip Morris Products S.A. and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philip Morris Products S.A.

Data source: Philip Morris Products S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo, Japan